The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD.
Chandani Patel ChavezKenneth CusiSushma KadiyalaPublished in: The Journal of clinical endocrinology and metabolism (2021)
A paradigm change is developing between the endocrinologist's greater awareness about their critical role to curve the epidemic of NAFLD and new clinical care pathways that include a broader use of GLP-1RAs in the management of these complex patients.